Adrian Will Orrego
About Adrian Will Orrego
Adrian Will Orrego is an Associate Scientist at Bristol Myers Squibb in Seattle, Washington, with over 7 years of experience in the pharmaceuticals industry.
Company: Bristol Myers Squibb
Adrian Will Orrego is currently working at Bristol Myers Squibb as an Associate Scientist in Seattle, Washington, United States. In his role, he contributes to scientific research and development, utilizing his extensive experience in molecular biology and image analysis to support the company's initiatives in the pharmaceutical industry.
Title: Associate Scientist
Adrian Will Orrego holds the title of Associate Scientist at Bristol Myers Squibb. His responsibilities likely include conducting experiments, analyzing data, and collaborating with other scientists to drive innovation and progress in biomedical research.
Past Experience at Juno Therapeutics, Inc.
Prior to his current role, Adrian Will Orrego served as a Senior Research Associate at Juno Therapeutics, Inc. from 2020 to 2022. During his two years there, he was based in Seattle, Washington, where he applied his skills in molecular biology and high throughput imaging to advance the company's research objectives.
Past Experience at Novartis Institutes for BioMedical Research
Adrian Will Orrego has an extensive history with Novartis Institutes for BioMedical Research (NIBR). He worked as a Scientist 1 from 2014 to 2019 in Cambridge, Massachusetts. Before that, he completed two Co-Op Intern stints at NIBR in 2013 and 2014, gaining valuable hands-on experience in the industry. His work at Novartis provided him with a solid foundation in scientific research and professional development.
Education and Expertise
Adrian Will Orrego has a strong academic background, having earned a Master of Liberal Arts (ALM) in Biotechnology from Harvard University Extension School, which he attended from 2015 to 2020. He also holds a Bachelor of Science (B.S.) in Biology, General from Northeastern University, completing his undergraduate studies from 2010 to 2014. His education has equipped him with specialized knowledge in high throughput imaging modalities of ex vivo tissues and adherent cells, as well as skills in molecular biology techniques and image analysis.